Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,278,088
-
Total 13F shares
-
12,281,745
-
Share change
-
+1,943,473
-
Total reported value
-
$661,113,412
-
Put/Call ratio
-
92%
-
Price per share
-
$53.83
-
Number of holders
-
167
-
Value change
-
+$105,431,066
-
Number of buys
-
115
-
Number of sells
-
36
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q2 2023
As of 30 Jun 2023,
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) was held by
167 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,281,745 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Rubric Capital Management LP, DIMENSIONAL FUND ADVISORS LP, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Deep Track Capital, LP, STATE STREET CORP, Global Alpha Capital Management Ltd., Ranger Investment Management, L.P., and THOMPSON SIEGEL & WALMSLEY LLC.
This page lists
168
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.